Maccura Biotechnology Co Ltd (300463) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Maccura Biotechnology Co Ltd (300463) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥148.82 Million ≈ $21.78 Million USD) by net assets (CN¥6.38 Billion ≈ $933.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Maccura Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Maccura Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300463 current and long-term liabilities for a breakdown of total debt and financial obligations.

Maccura Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Maccura Biotechnology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guoguang Electric Co Ltd SHE:002045	0.004x
GlaxoSmithKline PLC LSE:GSK	0.141x
Banco da Amazônia S.A SA:BAZA3	-0.160x
Genco Shipping & Trading Ltd NYSE:GNK	0.009x
Asiainfo Security Technologies Corp. A SHG:688225	N/A
Universal Insurance Holdings Inc NYSE:UVE	0.126x
Pharming Group NV AS:PHARM	0.121x
Zhejiang Cayi Vacuum Container Co. Ltd. SHE:301004	0.126x

Annual Cash Flow Conversion Efficiency for Maccura Biotechnology Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Maccura Biotechnology Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 300463 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.42 Billion ≈ $939.98 Million	CN¥633.80 Million ≈ $92.74 Million	0.099x	-28.48%
2023-12-31	CN¥6.61 Billion ≈ $967.46 Million	CN¥912.09 Million ≈ $133.47 Million	0.138x	+6.83%
2022-12-31	CN¥6.53 Billion ≈ $955.50 Million	CN¥843.22 Million ≈ $123.39 Million	0.129x	-63.72%
2021-12-31	CN¥4.54 Billion ≈ $664.60 Million	CN¥1.62 Billion ≈ $236.57 Million	0.356x	+30.32%
2020-12-31	CN¥4.01 Billion ≈ $586.12 Million	CN¥1.09 Billion ≈ $160.09 Million	0.273x	+97.80%
2019-12-31	CN¥3.33 Billion ≈ $486.94 Million	CN¥459.52 Million ≈ $67.24 Million	0.138x	+104.03%
2018-12-31	CN¥2.86 Billion ≈ $419.24 Million	CN¥193.91 Million ≈ $28.37 Million	0.068x	+123.77%
2017-12-31	CN¥2.61 Billion ≈ $382.37 Million	CN¥79.03 Million ≈ $11.57 Million	0.030x	+40.04%
2016-12-31	CN¥2.28 Billion ≈ $334.12 Million	CN¥49.32 Million ≈ $7.22 Million	0.022x	+30.20%
2015-12-31	CN¥2.00 Billion ≈ $292.73 Million	CN¥33.18 Million ≈ $4.86 Million	0.017x	-88.58%
2014-12-31	CN¥792.05 Million ≈ $115.90 Million	CN¥115.09 Million ≈ $16.84 Million	0.145x	-10.73%
2013-12-31	CN¥604.48 Million ≈ $88.46 Million	CN¥98.39 Million ≈ $14.40 Million	0.163x	-35.02%
2012-12-31	CN¥442.98 Million ≈ $64.82 Million	CN¥110.96 Million ≈ $16.24 Million	0.250x	-8.71%
2011-12-31	CN¥311.77 Million ≈ $45.62 Million	CN¥85.55 Million ≈ $12.52 Million	0.274x	--

About Maccura Biotechnology Co Ltd

SHE:300463 China Diagnostics & Research

Market Cap

$928.17 Million

CN¥6.34 Billion CNY

Market Cap Rank

#9424 Global

#2586 in China

Share Price

CN¥10.49

Change (1 day)

-0.94%

52-Week Range

CN¥10.39 - CN¥14.20

All Time High

CN¥59.01